Opera hits the roof with $115m US listing

Jonathan Breen

July 27, 2018 06:00 am

Nasdaq_PA_230x150 — The digital display on NASDAQ advertises the recent initial public offering of Sienna Biopharmaceuticals on Thursday, July 27, 2017. The pharmaceutical company focuses on developing treatments for dermatological skin conditions and diseases. (Photo by Richard B. Levine) *** Please Use Credit from Credit Field *** | Richard B. Levine/SIPA USA/PA Images

Web browser Opera has bagged $115m from its Nasdaq IPO after a flood of demand made top-end pricing a certainty, according to a source close to the deal.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOs Equity China China International Capital Corp Americas Citi Asia Greater China Northeast Asia Asia Pacific United States Emerging Markets North America

JB

Jonathan Breen

Equities editor GlobalCapital Asia